logo
Select company
Select metric
$ -2.58Operating Cash Flow per Share
VS
Market
8
Sector
22
Industry
31
History
58
$ 18Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information

Ticker

URGN

Company Name

UROGEN PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UROGEN PHARMA LTD - Operating Cash Flow per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

URGN - OCFPS Historical data
DateNet Cash Flow - OperationsOperating Cash Flow per ShareShare FactorWeighted Average Shares
6/30/2025$ -123.13M$ -2.58147.74M
3/31/2025$ -107.06M$ -2.26147.42M
12/31/2024$ -96.77M$ -2.26142.88M
9/30/2024$ -96.14M$ -2.23143.1M
6/30/2024$ -85.78M$ -2.33136.82M
3/31/2024$ -82.3M$ -2.47133.38M
12/31/2023$ -76.38M$ -2.65128.83M
9/30/2023$ -85.13M$ -2.64132.3M
6/30/2023$ -85.44M$ -3.64123.46M
3/31/2023$ -89.37M$ -3.84123.28M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UROGEN PHARMA LTD's latest trailing twelve months (TTM) OCFPS stands at $ -5.02.
  • Over the past 5 years, UROGEN PHARMA LTD's average OCFPS has been $ -3.4.
  • The median OCFPS for UROGEN PHARMA LTD during this period was $ -3.7
  • UROGEN PHARMA LTD reached its highest OCFPS over the past 5 years at $ -2.23.
  • The lowest OCFPS recorded by UROGEN PHARMA LTD in the same timeframe $ -5.02

UROGEN PHARMA LTD's OCFPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCFPS Benchmarks
CompanyOCFPS
NRIX : NURIX THERAPEUTICS INC $ -2.74SNDX : SYNDAX PHARMACEUTICALS INC $ -3.51GYRE : GYRE THERAPEUTICS INC $ 0.01CRMD : CORMEDIX INC $ 0.45NAGE : NIAGEN BIOSCIENCE INC $ 0.27ZYME : ZYMEWORKS INC $ -0.51PHAT : PHATHOM PHARMACEUTICALS INC $ -3.79TBPH : THERAVANCE BIOPHARMA INC $ 4.88WVE : WAVE LIFE SCIENCES LTD $ -1.21KURA : KURA ONCOLOGY INC $ 1.43

Similar metrics to Shares WA:

Definition of Operating Cash Flow per Share

[Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS OCFPS for UROGEN PHARMA LTD is calculated as follows: CF - Operations [ $ -110.64M ] / (Shares WA [ 22.06M ] * Share Factor [ 1 ])
(=) OCFPS [ $ -5.02 ]

URGN - Operating Cash Flow per Share, Last 5 years

$ -5.02

Minimum

Sep 30, 2020

$ -2.23

Maximum

Sep 30, 2024

$ -3.4

Average

$ -3.7

Median

OCFPS Benchmark Analysis

 The chart above depicts the distribution of OCFPS for companies in the Total Stock Market. The average OCFPS of the companies is $ 1.65 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
OCFPS in the Market:
filtered constituents3.79K
min$ -9.04
max$ 11.43
average$ 1.65
median$ 0.89
std$ 3.42